Benzinga | Sep 1, 2020 07:32AM EDT

Accuray Highlights Use Of Radixact System With Synchrony Technology By University Hospital Citt Della Salute E Della Scienza In Italy

SUNNYVALE, Calif., Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced today that the medical care team at University Hospital Citt? della Salute e della Scienza, in Turin, Italy have treated the first cancer patients in the Europe, India, Middle East and Africa (EIMEA) region using the Radixact(r) System with Synchrony(r) Automatic, Real-time Motion Synchronization Technology[1]. The Accuray-exclusive Synchrony technology leverages the Radixact System's fully integrated, real-time imaging to automatically adapt the treatment delivery to cancer targets as they move during treatment. The result is truly personalized care -- the treatment is adapted to the individual and unique movements of each patient or the treatment target throughout the entire radiation delivery session.